Algert Global LLC Incyte Corp Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $177,918 - $214,654	-2,420 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$63.56 - $88.17 $334,262 - $463,686	-5,259 Reduced 68.49%	2,420 $208,000
Q4 2018 Feb 01, 2019	SELL	$58.5 - $69.94 $15,385 - $18,394	-263 Reduced 3.31%	7,679 $488,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $490,418 - $589,534	7,942 New	7,942 $549,000

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.